Back
Creative Realities Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
26
CREX
Creative Realities
Last Price:
$1.93
Seasonality Move:
14.35%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
26
Creative Realities (CREX)
is a Sell
Is Creative Realities a Buy, Sell or Hold?
-
The current Creative Realities [CREX] share price is $1.96. The Score for CREX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
CREX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CREX Stock Price Chart
What is Creative Realities's stock price today?
-
The Creative Realities share price today is $1.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CREX is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $268.46The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
CREX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.54 | Buy |
Relative Strength Index (14 RSI): | 43.59 | Sell |
Chaikin Money Flow: | -13417 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.82 - 2.2) | Sell |
Bollinger Bands (100): | (2.09 - 3.41) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.41 | Buy |
Relative Strength Index (14 RSI): | 55.64 | Buy |
Chaikin Money Flow: | 78938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.82 - 268.04) | Buy |
Bollinger Bands (100): | (240.65 - 270.25) | Buy |
CREX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2 | Sell |
20-day SMA: | 1.93 | Buy |
50-day SMA: | 2.27 | Sell |
200-day SMA: | 3.62 | Sell |
8-day EMA: | 1.65 | Buy |
20-day EMA: | 1.01 | Buy |
50-day EMA: | 0.49 | Buy |
200-day EMA: | 0.14 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 271.33 | Sell |
20-day SMA: | 255.41 | Buy |
50-day SMA: | 259.88 | Buy |
200-day SMA: | 253.94 | Buy |
8-day EMA: | 268.64 | Sell |
20-day EMA: | 261.32 | Buy |
50-day EMA: | 257.88 | Buy |
200-day EMA: | 244.57 | Buy |
Creative Realities Earnings Growth & CREX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Creative Realities Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |